APPLICATION
ANDA204616
TYPE
ANDA
ORIGINAL APPROVAL
2016-05-11
LATEST ACTION
2016-05-11
ROUTE
INTRAVENOUS
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
OXALIPLATINPrescription
OXALIPLATIN 50MG/VIAL · INJECTABLE · INTRAVENOUS
OXALIPLATINPrescription
OXALIPLATIN 100MG/VIAL · INJECTABLE · INTRAVENOUS
Approval history
2016-05-11UNKNOWN · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.